Literature DB >> 30685676

Comparison of the change in heart failure readmission and mortality rates between hospitals subject to hospital readmission reduction program penalties and critical access hospitals.

Alexander T Sandhu1, Paul A Heidenreich2.   

Abstract

BACKGROUND: The Hospital Readmission Reduction Program (HRRP), announced in 2010, penalizes hospitals with high readmissions for multiple conditions including heart failure.
METHODS: We compared heart failure readmission and mortality rates in hospitals exposed to HRRP financial penalties with critical access hospitals (CAHs) not subject to the penalty between 2005 and 2016 using 3-year moving averages from Hospital Compare.
RESULTS: After HRRP introduction, CAHs experienced a 0.60% annual decrease (95% CI: -0.61 to -0.59%) in heart failure readmissions. HRRP-exposed hospitals experienced an additional 0.13% annual decrease (95% CI: -0.14 to -0.12%) compared with CAHs. The association between HRRP penalties and mortality varied with model specifications.
CONCLUSIONS: Using CAHs as a control group, we found the introduction of financial penalties was only associated with modest reductions in readmissions and an uncertain association with mortality. Cluster-randomized rollouts of health care policy interventions will allow us to better evaluate the impact of our interventions.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30685676     DOI: 10.1016/j.ahj.2018.12.002

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  2 in total

1.  Hospital physicians' views on discharge and readmission processes: a qualitative study from Norway.

Authors:  Malin Knutsen Glette; Tone Kringeland; Olav Røise; Siri Wiig
Journal:  BMJ Open       Date:  2019-08-27       Impact factor: 2.692

2.  Post-discharge acute care and outcomes following readmission reduction initiatives: national retrospective cohort study of Medicare beneficiaries in the United States.

Authors:  Rohan Khera; Yongfei Wang; Susannah M Bernheim; Zhenqiu Lin; Harlan M Krumholz
Journal:  BMJ       Date:  2020-01-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.